We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,705.00 | 1,701.00 | 1,701.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.21 | 70.03B |
TIDMGSK
RNS Number : 1470P
GlaxoSmithKline PLC
14 October 2021
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Ms E Walmsley ==== ====================================== ==================================================== b) Position/status Chief Executive Officer ==== ====================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 7 October 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================== ====================== GBP14.0080 956 =========================================== ========================== ====================== GBP14.0080 769 ========================== ====================== GBP14.0080 640 ========================== ====================== d) Aggregated information 2,365 ==== Aggregated volume GBP14.0080 Price =========================================== ==================================================== e) Date of the transaction 2021-10-11 ==== ====================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== =========================================================================================== a) Name Mr I Mackay ==== ===================================== ==================================================== b) Position/status Chief Financial Officer ==== ===================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ===================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== =========================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== =========================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 7 October 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ===================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== =========================== ===================== GBP 14.0080 519 ========================================== =========================== ===================== GBP14.0080 443 =========================== ===================== d) Aggregated information 962 ==== Aggregated volume GBP14.0080 Price ========================================== ==================================================== e) Date of the transaction 2021-10-11 ==== ===================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Dr H Barron ==== ======================================= =================================================== b) Position/status Chief Scientific Officer and President, R&D ==== ======================================= =================================================== c) Initial notification/ Initial notification amendment ==== ======================================= =================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ======================================= =================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================= =================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument ==== ======================================= =================================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 7 October 2021 on ADSs held in the Company's Deferred Annual Bonus Plan ==== ======================================= =================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================= ========================= ====================== $ 38.6600 557
============================================ ========================= ====================== $ 38.6600 437 ========================= ====================== $ 38.6600 331 ========================= ====================== d) Aggregated information 1,325 ==== Aggregated volume $ 38.6600 Price ============================================ =================================================== e) Date of the transaction 2021-10-11 ==== ======================================= =================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================= =================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr R Connor ==== ====================================== ==================================================== b) Position/status President, Vaccines & Global Health ==== ====================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 7 October 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================== ====================== GBP14.0080 250 =========================================== ========================== ====================== GBP14.0080 242 ========================== ====================== GBP14.0080 140 ========================== ====================== d) Aggregated information 632 ==== Aggregated volume GBP 14.0080 Price =========================================== ==================================================== e) Date of the transaction 2021-10-11 ==== ====================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== =========================================================================================== a) Name Ms D Conrad ==== ===================================== ==================================================== b) Position/status SVP Human Resources ==== ===================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ===================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== =========================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== =========================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 7 October 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ===================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== =========================== ===================== GBP 14.0080 100 ========================================== =========================== ===================== GBP 14.0080 92 =========================== ===================== d) Aggregated information 192 ==== Aggregated volume GBP14.0080 Price ========================================== ==================================================== e) Date of the transaction 2021-10-11 ==== ===================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr J Ford ==== ====================================== ==================================================== b) Position/status Senior Vice President and General Counsel ==== ====================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882
==== ====================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 7 October 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================== ====================== GBP14.0080 142 =========================================== ========================== ====================== GBP14.0080 111 ========================== ====================== d) Aggregated information 253 ==== Aggregated volume GBP14.0080 Price =========================================== ==================================================== e) Date of the transaction 2021-10-11 ==== ====================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================= a) Name Mr J Ford ==== ======================================= ==================================================== b) Position/status Senior Vice President and General Counsel ==== ======================================= ==================================================== c) Initial notification/ Initial notification amendment ==== ======================================= ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================= a) Name GlaxoSmithKline plc ==== ======================================= ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================= ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument ==== ======================================= ==================================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 7 October 2021 on ADSs held in the Company's Deferred Annual Bonus Plan ==== ======================================= ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================= ========================= ====================== $ 38.6600 47 ========================= ====================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ======================================== ======================================================== e) Date of the transaction 2021-10-11 ==== ======================================= ==================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================= ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== =========================================================================================== a) Name Ms S Jackson ==== ===================================== ==================================================== b) Position/status SVP, Global Communications & CEO Office ==== ===================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ===================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== =========================================================================================== a) Name GlaxoSmithKline plc ==== ===================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ===================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== =========================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ===================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 7 October 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ===================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ===================================== =========================== ===================== GBP 14.0080 60 ========================================== =========================== ===================== GBP 14.0080 56 =========================== ===================== d) Aggregated information 116 ==== Aggregated volume GBP14.0080 Price ========================================== ==================================================== e) Date of the transaction 2021-10-11 ==== ===================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ===================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr B McNamara ==== ======================================= =================================================== b) Position/status CEO, GSK Consumer Healthcare ==== ======================================= =================================================== c) Initial notification/ Initial notification amendment ==== ======================================= =================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ======================================= =================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================= =================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s)
has been conducted ==== ============================================================================================ a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument ==== ======================================= =================================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 7 October 2021 on ADSs held in the Company's Deferred Annual Bonus Plan ==== ======================================= =================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== --------------------------------------- ========================= ====================== $ 38.6600 93 -------------------------------------------- ========================= ====================== $ 38.6600 80 ========================= ====================== $ 38.6600 101 ------------------------- ---------------------- d) Aggregated information 274 ==== Aggregated volume $ 38.6600 Price ============================================ =================================================== e) Date of the transaction 2021-10-11 ==== ======================================= =================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================= =================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr L Miels ==== ====================================== ==================================================== b) Position/status Chief Commercial Officer ==== ====================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 7 October 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================== ====================== GBP14.0080 266 =========================================== ========================== ====================== GBP14.0080 232 ========================== ====================== GBP14.0080 173 ========================== ====================== d) Aggregated information 671 ==== Aggregated volume GBP14.0080 Price =========================================== ==================================================== e) Date of the transaction 2021-10-11 ==== ====================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr D Redfern ==== ====================================== ==================================================== b) Position/status Chief Strategy Officer ==== ====================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 7 October 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================== ====================== GBP14.0080 237 =========================================== ========================== ====================== GBP14.0080 170 ========================== ====================== GBP14.0080 136 ========================== ====================== d) Aggregated information 543 ==== Aggregated volume GBP14.0080 Price =========================================== ==================================================== e) Date of the transaction 2021-10-11 ==== ====================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr R Simard ==== ====================================== ==================================================== b) Position/status President, Pharmaceuticals Supply Chain
==== ====================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 7 October 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================== ====================== GBP14.0080 85 =========================================== ========================== ====================== GBP14.0080 120 ========================== ====================== GBP14.0080 102 ========================== ====================== d) Aggregated information 307 ==== Aggregated volume GBP14.0080 Price =========================================== ==================================================== e) Date of the transaction 2021-10-11 ==== ====================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Ms K Terrell ==== ======================================= =================================================== b) Position/status Chief Digital & Technology Officer ==== ======================================= =================================================== c) Initial notification/ Initial notification amendment ==== ======================================= =================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ======================================= =================================================== b) LEI 5493000HZTVUYLO1D793 ==== ======================================= =================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument ==== ======================================= =================================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 7 October 2021 on ADSs held in the Company's Deferred Annual Bonus Plan ==== ======================================= =================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ======================================= ========================= ====================== $ 38.6600 118 ============================================ ========================= ====================== $ 38.6600 81 ========================= ====================== $ 38.6600 63 ========================= ====================== d) Aggregated information 262 ==== Aggregated volume $ 38.6600 Price ============================================ =================================================== e) Date of the transaction 2021-10-11 ==== ======================================= =================================================== f) Place of the New York Stock Exchange (XNYS) transaction ==== ======================================= =================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================ a) Name Mr P Thomson ==== ====================================== ==================================================== b) Position/status President, Global Affairs ==== ====================================== ==================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ==================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================ a) Name GlaxoSmithKline plc ==== ====================================== ==================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ==================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================ a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ==================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 7 October 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ==================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== ========================== ====================== GBP14.0080 138 =========================================== ========================== ====================== GBP14.0080 98 ========================== ====================== GBP14.0080 79
========================== ====================== d) Aggregated information 315 ==== Aggregated volume GBP14.0080 Price =========================================== ==================================================== e) Date of the transaction 2021-10-11 ==== ====================================== ==================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ==================================================== 1. Details of PDMR/person closely associated with them ('PCA') ==== ============================================================================================== a) Name Ms D Waterhouse ==== ====================================== ====================================================== b) Position/status Chief Executive Officer of ViiV Healthcare ==== ====================================== ====================================================== c) Initial notification/ Initial notification amendment ==== ====================================== ====================================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ==== ============================================================================================== a) Name GlaxoSmithKline plc ==== ====================================== ====================================================== b) LEI 5493000HZTVUYLO1D793 ==== ====================================== ====================================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted ==== ============================================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 ==== ====================================== ====================================================== b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 7 October 2021 on Ordinary Shares held in the Company's Deferred Annual Bonus Plan ==== ====================================== ====================================================== c) Price(s) and Price(s) Volume(s) volume(s) ==== ====================================== =========================== ====================== GBP14.0080 163 ======================================================================= ====================== d) Aggregated information N/A (single transaction) ==== Aggregated volume Price ==================================================================== ============================= e) Date of the transaction 2021-10-11 ==== ====================================== ====================================================== f) Place of the London Stock Exchange (XLON) transaction ==== ====================================== ======================================================
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEZLFFFBLXFBB
(END) Dow Jones Newswires
October 14, 2021 11:31 ET (15:31 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions